Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of onset age on the clinical features of Parkinson’s disease
Mirdhu Wickremaratchi, Yoav Ben‐Shlomo, Huw R. Morris
European Journal of Neurology (2009) Vol. 16, Iss. 4, pp. 450-456
Closed Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

Pharmacological Treatment of Parkinson Disease
Barbara S. Connolly, Anthony E. Lang
JAMA (2014) Vol. 311, Iss. 16, pp. 1670-1670
Closed Access | Times Cited: 1312
An update on the diagnosis and treatment of Parkinson disease
Philippe Rizek, Niraj Kumar, Mandar Jog
Canadian Medical Association Journal (2016) Vol. 188, Iss. 16, pp. 1157-1165
Open Access | Times Cited: 381
Age at onset and Parkinson disease phenotype
Gennaro Pagano, Nicola Ferrara, David J. Brooks, et al.
Neurology (2016) Vol. 86, Iss. 15, pp. 1400-1407
Open Access | Times Cited: 304
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
Olivier Rascol, Cheryl Fitzer‐Attas, Robert A. Hauser, et al.
The Lancet Neurology (2011) Vol. 10, Iss. 5, pp. 415-423
Closed Access | Times Cited: 209
Enhanced striatal cholinergic neuronal activity mediatesl-DOPA–induced dyskinesia in parkinsonian mice
Yunmin Ding, Lisa Won, Jonathan P. Britt, et al.
Proceedings of the National Academy of Sciences (2010) Vol. 108, Iss. 2, pp. 840-845
Open Access | Times Cited: 179
Systematic Review and UK‐Based Study of PARK2 (parkin), PINK1, PARK7 (DJ‐1) and LRRK2 in early‐onset Parkinson's disease
Laura L. Kilarski, Justin Pearson, Victoria Newsway, et al.
Movement Disorders (2012) Vol. 27, Iss. 12, pp. 1522-1529
Closed Access | Times Cited: 165
Structural, functional and molecular imaging of the brain in primary focal dystonia—A review
Evelien Zoons, Jan Booij, Aart J. Nederveen, et al.
NeuroImage (2011) Vol. 56, Iss. 3, pp. 1011-1020
Closed Access | Times Cited: 150
The motor phenotype of Parkinson's disease in relation to age at onset
Mirdhu Wickremaratchi, Duleeka Knipe, B. S. D. Sastry, et al.
Movement Disorders (2011) Vol. 26, Iss. 3, pp. 457-463
Closed Access | Times Cited: 144
Comparing clinical features of young onset, middle onset and late onset Parkinson's disease
Raja Mehanna, Suzanne Moore, Jyhgong Gabriel Hou, et al.
Parkinsonism & Related Disorders (2014) Vol. 20, Iss. 5, pp. 530-534
Closed Access | Times Cited: 129
A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease
Peter Holmans, Valentina Moskvina, Lesley Jones, et al.
Human Molecular Genetics (2012) Vol. 22, Iss. 5, pp. 1039-1049
Open Access | Times Cited: 125
Levodopa-induced dyskinesia: clinical features, incidence, and risk factors
Tai Ngoc Tran, Trang N. N. Vo, Karen Frei, et al.
Journal of Neural Transmission (2018) Vol. 125, Iss. 8, pp. 1109-1117
Closed Access | Times Cited: 119
α-Synuclein Genetic Variants Predict Faster Motor Symptom Progression in Idiopathic Parkinson Disease
Beate Ritz, Shannon Rhodes, Yvette Bordelon, et al.
PLoS ONE (2012) Vol. 7, Iss. 5, pp. e36199-e36199
Open Access | Times Cited: 110
Young-onset Parkinson's disease: Its unique features and their impact on quality of life
Raja Mehanna, Joseph Jankovic
Parkinsonism & Related Disorders (2019) Vol. 65, pp. 39-48
Closed Access | Times Cited: 102
Early-onset vs. Late-onset Parkinson’s disease: A Clinical-pathological Study
Leslie W. Ferguson, Ali H. Rajput, Alexander Rajput
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (2015) Vol. 43, Iss. 1, pp. 113-119
Open Access | Times Cited: 94
Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data
Kin Y. Mok, Una Sheerin, Javier Simón‐Sánchez, et al.
The Lancet Neurology (2016) Vol. 15, Iss. 6, pp. 585-596
Open Access | Times Cited: 89
Global Characterization of Peripheral B Cells in Parkinson’s Disease by Single-Cell RNA and BCR Sequencing
Pingping Wang, Meng Luo, Wenyang Zhou, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Neurodegenerative Diseases: Their Onset, Epidemiology, Causes and Treatment
Sumera Zaib, Hira Javed, Imtiaz Khan, et al.
ChemistrySelect (2023) Vol. 8, Iss. 20
Closed Access | Times Cited: 24
Parkinson's Disease – the Debate on the Clinical Phenomenology, Aetiology, Pathology and Pathogenesis
Peter Jenner, Huw R. Morris, Trevor W. Robbins, et al.
Journal of Parkinson s Disease (2013) Vol. 3, Iss. 1, pp. 1-11
Open Access | Times Cited: 95
Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson’s disease
Vladana Špica, Tatjana Pekmezović, Marina Svetel, et al.
Journal of Neurology (2012) Vol. 260, Iss. 1, pp. 131-137
Closed Access | Times Cited: 88
Gender and onset age-related features of non-motor symptoms of patients with Parkinson's disease – A study from Southwest China
Xiaoyan Guo, Wei Song, Ke Chen, et al.
Parkinsonism & Related Disorders (2013) Vol. 19, Iss. 11, pp. 961-965
Closed Access | Times Cited: 86
Timing of deep brain stimulation in Parkinson disease: A need for reappraisal?
Ruth‐Mary deSouza, Elena Moro, Anthony E. Lang, et al.
Annals of Neurology (2013) Vol. 73, Iss. 5, pp. 565-575
Open Access | Times Cited: 84
Therapy of Parkinson’s Disease Subtypes
Connie Marras, К. Ray Chaudhuri, Nataliya Titova, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1366-1377
Open Access | Times Cited: 68
Parkinsonism and Related Disorders
Elizabeth Slow, Anthony E. Lang
DeckerMed Transitional Year Weekly Curriculum™ (2019)
Closed Access | Times Cited: 61
Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease
Seok Jong Chung, John Hoon Rim, Dajeong Ji, et al.
Nutrition (2020) Vol. 83, pp. 111090-111090
Closed Access | Times Cited: 55
Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention
Pavan A. Vaswani, Thomas F. Tropea, Nabila Dahodwala
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1724-1735
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top